Literature DB >> 2364472

[Effect of oxymatrine on prolonging the survival time of cardiac tissue allograft in mice and its immunologic mechanisms].

Z Qin1, H Den, H Zhuang.   

Abstract

Oxymatrine is an extract from Sophora flavescens Ait. A daily dose of 75 mg/kg or 225 mg/kg of oxymatrine was given to the recipient intramuscularly for 14 days. The survival time of cardiac tissue allograft was prolonged significantly to 12.2 days (at the dose of 75 mg/kg, P less than 0.05) and 15.7 days (at the dose of 225 mg/kg, P less than 0.001) by oxymatrine, while that in the control group was 10.8 days. The effects of oxymatrine on immune-function in BABL/c mice with or without heart allograft were further studied. Experiments showed that in vitro spontaneous proliferation of spleen cells increased markedly on the 10th day after transplantation, while the proliferation response to Con A of spleen cells decreased. The spontaneous proliferation and proliferation responses to Con A or to LPS of spleen cells could be inhibited significantly in normal mice by oxymatrine. The proliferation response to LPS of spleen cells and RPFC was inhibited obviously in transplanted mice by oxymatrine. However, oxymatrine did not affect the proliferation response to Con A of spleen cells, which had been decreased after transplantation. The results suggested that this drug exhibited selective immuno-suppression on function of B cells without obvious effect on T cell function in transplanted mice. This characteristics of the drug seemed beneficial for avoiding side-effect produced by the conventional immuno-suppressive agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364472

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Za Zhi        ISSN: 0254-9034


  3 in total

1.  Anti-apoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats.

Authors:  Hongchi Jiang; Fanqiang Meng; Jie Li; Xueying Sun
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

2.  Application of kushenin on patients with chronic hepatitis C after renal transplantation.

Authors:  Yang Li; Wu-jun Xue; Ping Fan; Chen-guang Ding; Huan-jin Song; Xiao-ming Ding; Xin-shun Feng
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

3.  Antitumor activities of kushen: literature review.

Authors:  Mingyu Sun; Hongyan Cao; Lin Sun; Shu Dong; Yanqin Bian; Jun Han; Lijun Zhang; Shuang Ren; Yiyang Hu; Chenghai Liu; Lieming Xu; Ping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-28       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.